# Cagrilintide 10mg

Price: $124.00

A long-acting amylin analogue studied for satiety signaling, appetite, body-weight regulation, and metabolic research.

## Overview

Cagrilintide is a lipidated, long-acting analogue of amylin, a pancreatic hormone involved in satiety and energy balance. It activates amylin and calcitonin receptors rather than the GLP-1 receptor.

Research focuses on how this receptor system influences food intake and body-weight regulation. Cagrilintide has been studied on its own in randomized human trials, and separately as the amylin component of CagriSema alongside semaglutide.

Dedicated phase 3 studies are underway, but cagrilintide remains investigational and is not FDA-approved.

## Research

- [Once-weekly Cagrilintide for Weight Management in People with Overweight and Obesity (The Lancet, 2021)](https://pubmed.ncbi.nlm.nih.gov/34798060/)
- [Development of Cagrilintide, a Long-Acting Amylin Analogue (Journal of Medicinal Chemistry, 2021)](https://pubmed.ncbi.nlm.nih.gov/34288673/)

## Library

- [Storing research peptides and bacteriostatic water](https://curo.you/help/storage-stability/storing-research-peptides-and-bacteriostatic-water)
- [Certificates of Analysis: how to verify your lot](https://curo.you/help/quality-verification/certificates-of-analysis-how-to-verify-your-lot)
- [Reconstituting a research peptide](https://curo.you/help/getting-started/reconstituting-a-research-peptide)

## Documentation

LOT-specific third-party lab reports (COAs) are linked from the product page and the [COA lookup](https://curo.you/coa).

---

Research use only. Not for human or veterinary use. Curo is operated by Mira Labs LLC.

Canonical: https://curo.you/products/cagrilintide-10mg
Site guide for agents: https://curo.you/llms.txt
